Nikhil Munshi, M.D on KarMMa in Relapsed Refractory MM #ASCO2020

Nikhil C. Munshi, M.D of Dana Farber Cancer Institute discusses the positive results from pivotal KarMMa study of Ide-cel in MM

Read here: https://news.bms.com/press-release/corporatefinancial-news/bristol-myers-squibb-and-bluebird-bio-present-updated-positive